Iveric bio | OPHT - Ebit



Ebit Veränderung Datum
Bioline Rx USD -2.34M 1.05M 2026-03
Insmed USD -101.31M 98.97M 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 4.73B 549M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06